Non-inferiority testing for qualitative microbiological methods: Assessing and improving the approach in USP 1223

Pieta C. IJzerman-Boon, Md Abu Manju, Edwin R. van den Heuvel (Corresponding author)

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)
121 Downloads (Pure)

Abstract

The United States Pharmacopoeia (USP) presents two approaches for showing non-inferiority of an alternate qualitative microbiological method versus a compendial method. One approach compares the positive rates for the alternate and compendial methods at one spike level, while the other one compares multiple most probable number (MPN) estimates from a multi-spike design using a t-test. In this paper, we discuss these approaches under certain assumptions and propose a third approach that can be used for both single and multiple dilutions, which we call the generalized MPN (gMPN) approach. Simulations, using Poisson distributed numbers of microorganisms in test samples, confirm that the USP approach based on rates is not suitable, that the USP approach based on MPNs is appropriate for non-inferiority, but the gMPN approach outperforms the MPN-based approach and is therefore recommended.

Original languageEnglish
Pages (from-to)915-941
Number of pages27
JournalJournal of Biopharmaceutical Statistics
Volume32
Issue number6
Early online date21 Sept 2022
DOIs
Publication statusPublished - 2 Nov 2022

Bibliographical note

Publisher Copyright:
© 2022 The Author(s). Published with license by Taylor & Francis Group, LLC.

Keywords

  • Binomial detection
  • detection proportion
  • limit of detection
  • microbiological validation
  • most probable number
  • sterility tests
  • Humans
  • Microbiological Techniques

Fingerprint

Dive into the research topics of 'Non-inferiority testing for qualitative microbiological methods: Assessing and improving the approach in USP 1223'. Together they form a unique fingerprint.

Cite this